Overview
Centivax, a South San Francisco-based developer of a universal flu vaccine, raised $37 million in funding. The round was led by Structure Fund, with participation from Meiji Seika Pharma Co., Sigma's Group, Kendall Capital Partners, and Stripe founders Patrick and John Collison. The company plans to use the funds to advance its vaccine development.
Products
Loading...
Recent Deals
Investors: Structure Fund, Meiji Seika Pharma Co., Sigma's Group, Kendall Capital Partners, Patrick Collison, John Collison
Centivax, a South San Francisco-based developer of a universal flu vaccine, raised $37 million in funding. The round was led by Structure Fund, with participation from Meiji Seika Pharma Co., Sigma's Group, Kendall Capital Partners, and Stripe founders Patrick and John Collison. The company plans to use the funds to advance its vaccine development.